- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03706105
Integrating Stroke Survivors Into Cardiac Rehabilitation
November 2, 2020 updated by: Elizabeth Regan, University of South Carolina
The intervention trial will examine the effectiveness and feasibility of integrating stroke survivors into an existing hospital-based cardiac rehabilitation program at Novant Health in Charlotte, NC.
Stroke survivors will be recruited through hospital system providers and physical therapists (PTs) for entry into a multidisciplinary, three-month cardiac rehabilitation program.
This program consists of three sessions per week of supervised cardiovascular endurance and strength training, stretching, relaxation and education.
Participants will be stroke survivors, have completed formal physical and occupational rehabilitation (if applicable), and have treating provider approval.
Study Overview
Study Type
Interventional
Enrollment (Actual)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28204
- Novant Health Heart and Vascular Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of stroke
- Completion of physical and occupational therapy (if applicable)
- Clearance by treating medical provider
- Ability to walk at least 40 meters independently (with or without assistive device)
- Ability to transfer sit to stand without assistance
- Ability to follow instructions and provide information on exertion, pain and distress
Exclusion Criteria:
- Acute medical problem rendering exercise unsafe
- Significant pain that prevents standing or interferes with movement
- History of additional, non-stroke, neurological condition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention - Cardiac Rehabilitation
|
3 x week ~1 hour of exercise + education
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6-minute walk Test
Time Frame: Change in 6-minute walk test at 3 months
|
Aerobic and Walking Capacity Measure
|
Change in 6-minute walk test at 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Walking Speed
Time Frame: Change in Walking Speed at 3 months
|
Self-Selected walking speed for 10 meters
|
Change in Walking Speed at 3 months
|
Timed Up and Go
Time Frame: Change in timed up and go at 3 months
|
Mobility Measure: timed movement from seated in a chair, walk 10 feet and return to sitting in a chair.
|
Change in timed up and go at 3 months
|
Stroke Impact Scale
Time Frame: Change in Stroke Impact Scale at 3 months
|
Quality of Life Questionnaire evaluating difficulty after stroke in 8 domains: strength, hand function, activities of daily living, mobility, communication, emotion, memory/thinking, participation/role function.
Score is 0-100 in each domain and is transformed using the equation Domain score = (mean item score - 1)/4 * 100.
Higher Scores indicate less impact of stroke.
|
Change in Stroke Impact Scale at 3 months
|
Fatigue Severity Scale
Time Frame: Change in Fatigue Severity Scale at 3 months
|
A scale measuring the perceived impact of fatigue on life activities.
Total score is 9-63 with a higher score indicating more fatigue severity and impact.
|
Change in Fatigue Severity Scale at 3 months
|
Activities Specific Balance Confidence (ABC) Scale
Time Frame: Change in ABC Scale at 3 months
|
The Activities Specific Balance Confidence scale measures an individual's confidence in performing 16 activities without loss of balance.
Possible scores are 0-100 with higher scores indicating higher balance confidence.
|
Change in ABC Scale at 3 months
|
Readiness for Change Questionnaire
Time Frame: Change in Readiness/Confidence in Behaviors at 3 months
|
The readiness for change questionnaire evaluates self-perception of readiness and confidence in exercise, physical activity and overall wellness behaviors.
Readiness score is 3-15 with higher scores indicating higher readiness, and confidence score 3-9 with a higher score indicating more confidence in behavior.
|
Change in Readiness/Confidence in Behaviors at 3 months
|
Patient Health Questionnaire 9 (PHQ9)
Time Frame: Change in PHQ9 at 3 months
|
The patient health questionnaire is a 9 question self report measure of depression and depression severity.
The score is 0-27 with a higher score indicating more severe depression.
|
Change in PHQ9 at 3 months
|
Ferrans and Powers Quality of Life Questionnaire
Time Frame: Change in Ferrans and Powers Quality of Life Questionnaire at 3 months
|
Ferrans and Powers Quality of Life questionnaire is a measure of satisfaction and importance of 7 domains (health, healthcare, self-care, energy, family/friends support, engagement in life activities, happiness).
Raw scores are converted to overall scores by weighting satisfaction by importance and adjusting for unanswered questions.
Total scores are 0-30 with higher scores indicating a higher quality of life.
|
Change in Ferrans and Powers Quality of Life Questionnaire at 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Stacy L Fritz, PT, PhD, University of South Carolina
- Principal Investigator: Elizabeth Regan, DPT, University of South Carolina
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2018
Primary Completion (Actual)
May 30, 2020
Study Completion (Actual)
May 30, 2020
Study Registration Dates
First Submitted
April 25, 2018
First Submitted That Met QC Criteria
October 12, 2018
First Posted (Actual)
October 15, 2018
Study Record Updates
Last Update Posted (Actual)
November 3, 2020
Last Update Submitted That Met QC Criteria
November 2, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18-1001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Cardiac Rehabilitation
-
Wake Forest University Health SciencesRecruitingCardiac AmyloidosisUnited States
-
Lawson Health Research InstituteHeart and Stroke Foundation of OntarioCompleted
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Heart DiseaseUnited States
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR); AstraZenecaCompletedMyocardial Infarction | Coronary Disease | Unstable AnginaCanada
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; Johns Hopkins University; Mayo... and other collaboratorsRecruitingMyocardial Infarction | Coronary Artery Disease | Heart Valve Diseases | Angina, Stable | Heart Failure, Systolic | Heart TransplantUnited States
-
Federico II UniversityCompletedAcute Myocardial InfarctionItaly
-
Cairo UniversityNational Heart Institute, EgyptCompletedChronic Heart FailureEgypt
-
Women's College HospitalRecruiting
-
Fundación Pública Andaluza para la Investigación...UnknownHomebased Cardiac Rehabilitation Program After Ischemic Heart DiseaseSpain
-
Universidade do PortoCentro Hospitalar de Vila Nova de Gaia/Espinho; Research Center in Physical...CompletedCoronary Artery DiseasePortugal